U Rueffer

Summary

Country: Germany

Publications

  1. ncbi request reprint Spleen involvement in Hodgkin's lymphoma: assessment and risk profile
    U Rueffer
    First Department of Internal Medicine, University Hospital Cologne, Joseph Stelzmann Strasse 9, 50924 Cologne, Germany
    Ann Hematol 82:390-6. 2003
  2. ncbi request reprint Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)
    J U Rüffer
    Department of Internal Medicine I, TAKEPART, Maria Hilf Str 15, 50677 Köln, Germany
    Eur J Cancer 39:2179-86. 2003
  3. ncbi request reprint Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    A Josting
    First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    J Clin Oncol 18:332-9. 2000
  4. ncbi request reprint Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis
    U Rueffer
    First Department of Internal Medicine, University Hospital Cologne, Germany
    J Clin Oncol 19:2026-32. 2001
  5. ncbi request reprint Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment
    U Rueffer
    First Department of Internal Medicine, University Hospital Cologne, and the German Hodgkin's Study Group
    Ann Oncol 12:1307-11. 2001
  6. ncbi request reprint Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF
    M Pfreundschuh
    Department of Medicine, Saarland University Medical School, Germany
    Ann Oncol 12:471-7. 2001
  7. ncbi request reprint 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group
    M Sieber
    German Hodgkin s Lymphoma Study Group, Klinik fur Innere Medizin, University of Cologne, Germany
    J Clin Oncol 21:1734-9. 2003
  8. ncbi request reprint Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial
    M Sieber
    Klinik I fur Innere Medizin, University of Cologne, Cologne, Germany
    Ann Oncol 15:276-82. 2004

Detail Information

Publications8

  1. ncbi request reprint Spleen involvement in Hodgkin's lymphoma: assessment and risk profile
    U Rueffer
    First Department of Internal Medicine, University Hospital Cologne, Joseph Stelzmann Strasse 9, 50924 Cologne, Germany
    Ann Hematol 82:390-6. 2003
    ..Above an index of 1000 the probability of spleen involvement is higher than 90%. This might be of outstanding importance for patients being scheduled for involved field radiation...
  2. ncbi request reprint Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)
    J U Rüffer
    Department of Internal Medicine I, TAKEPART, Maria Hilf Str 15, 50677 Köln, Germany
    Eur J Cancer 39:2179-86. 2003
    ..Fatigue levels of Hodgkin's lymphoma patients are significantly higher than those of the control group. Further investigations are warranted to explore the effectiveness of treatment strategies for fatigue...
  3. ncbi request reprint Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    A Josting
    First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    J Clin Oncol 18:332-9. 2000
    ....
  4. ncbi request reprint Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis
    U Rueffer
    First Department of Internal Medicine, University Hospital Cologne, Germany
    J Clin Oncol 19:2026-32. 2001
    ..To investigate the course of disease for secondary NHL, we retrospectively analyzed patients treated within clinical trials of the German Hodgkin's Lymphoma Study Group (GHSG) since 1981...
  5. ncbi request reprint Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment
    U Rueffer
    First Department of Internal Medicine, University Hospital Cologne, and the German Hodgkin's Study Group
    Ann Oncol 12:1307-11. 2001
    ..Further investigations have to be performed to clarify mechanisms inducing fertility defects in patients with HD...
  6. ncbi request reprint Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF
    M Pfreundschuh
    Department of Medicine, Saarland University Medical School, Germany
    Ann Oncol 12:471-7. 2001
    ..The use of CSF for interval reduction rather than dose escalation is the more effective strategy for dose intensification...
  7. ncbi request reprint 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group
    M Sieber
    German Hodgkin s Lymphoma Study Group, Klinik fur Innere Medizin, University of Cologne, Germany
    J Clin Oncol 21:1734-9. 2003
    ....
  8. ncbi request reprint Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial
    M Sieber
    Klinik I fur Innere Medizin, University of Cologne, Cologne, Germany
    Ann Oncol 15:276-82. 2004
    ....